NCT00065130View on ClinicalTrials.gov

Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes

PHASE3CompletedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

December 31, 2003

Study Completion Date

December 31, 2003

Conditions

DiabetesGestational Diabetes

Interventions

DRUG

human insulin

DRUG

insulin NPH

DRUG

insulin aspart

Trial Locations (1)

93105

Novo Nordisk Investigational Site, Santa Barbara

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY